COMMON BACTERIAL PATHOGENS Flashcards
Endoxtoxic shock
LPS (endotoxin) is a very toxic molecule for humans. The toxic moiety, Lipid A, is embedded in the outer leaflet of the outer membrane of the Gram- negative cell wall. In many cases it is a significant component of the disease process of G- organisms. Even in minute quantities, LPS may cause fever and shock (IL-1 and TNF release). In larger doses, LPS may result in DRAMATIC life-threatening effects:
• Hypotension
• Hemorrhage
• Intravascular coagulation (activates clotting cascade)
Patients encounter LPS e.g., release of cell wall fragments following treatment with certain antibiotics, injection of contaminated materials, bacteremia.
General rules for antimicrobial susceptibility
The Gram-negative outer membrane is a permeability barrier that protects the cell from many organic materials, including some antibiotics, e.g., erythromycin.
(Gram + cocci) Genus staphylococcus
-Staphylococcus. aureus
Gram + Cocci
-SSNA (“staph species, not aureus” e.g. S. epidermidis)
Staphylococcus aureus background
Primary pathogenic species of the genus. Asymptomatic carriage in ~30% of healthy individuals. The sites
of carriage are primarily in the anterior nares and perineum. One’s endogenous infection can be source of bacterial infection to another person.
Staphylococcus aureus typical diseases: Cutaneous infection
The characteristic lesion is a localized abscess. Both the bacterium and the host contribute to the formation of a fibrinous capsule which tends to wall off the infection and limit spread to adjacent tissues. The fibrinous capsule also restricts access of phagocytic cells, antibodies, and antimicrobials, etc to the site of infection. Effective treatment typically includes drainage of the abscess. The enzyme “coagulase” is an essential virulence factor that is associated with formation of the fibrin capsule and deposition of fibrin on the cell surface- which interfers with phagocytosis. Alpha-toxin is the major cytotoxic agent released by bacterium Staphylococcus aureus and the first identified member of the pore forming beta-barrel toxin family. Cutaneous S. aureus infections are often associated with the presence of a “foreign body” at the site, e.g., a suture or splinter. The presence of such an object interferes with bacterial clearance by phagocytes and provides a surface for the bacterial to colonize.
Spread from the initial lesion occurs, and may result in bacteremia, sepsis or metastatic lesions
Staphylococcus aureus typical diseases: Toxin mediated diseases
Superantigen toxins are a class of antigens that cause non-specific activation of T-cells, resulting in polyclonal T cell activation and massive cytokine release. SAgs can be produced by pathogenic microbes (including viruses, mycoplasma, and bacteria) as a defense mechanism against the immune system. Compared to a normal antigen-induced T-cell response where .0001-.001% of the body’s T-cells are activated, these SAgs are capable of activating up to 25% of the body’s T- cells. Can lear to STAPHYLOCOCCAL TOXIC SHOCK SYNDROM and STAPHYLOCOCCAL FOOD POISONING
Toxic shock syndrome
Patients generally have a localized infection by a toxinogenic S. aureus strain; circulating toxin produced locally by bacteria at the site of infection results in severe systemic manifestations. typically manifests in otherwise healthy individuals with high fever, accompanied by low blood pressure, malaise and confusion, which can rapidly progress to stupor, coma, and multiple organ failure. The characteristic rash, often seen early in the course of illness, resembles a sunburn, and can involve any region of the body, including the lips, mouth, eyes, palms and soles. Toxin expression requires O2 neutral pH, high protein
High fever, shock, vomiting, muscle pain- renal and hepatic injury/failure
Staphylococcus aureus typical diseases: Pneumonia
specially in patients with impaired host defenses (particularly high mortality 50%). Although it is not a very common cause of pneumonia in patients who present to the clinic (outpatient), it is common isolate in patients who develop pneumonia once they are in the hospital or are recently or chronically associated with health care (health care-associated pneumonia (HCAP); hospital acquired-pneumonia (HAP); and ventilator-associated pneumonia (VAP).
Staphylococcus aureus typical diseases: foreig-body associated infections
vascular catheter-related infections, prosthetic joint infections, hardware infections (cardiac pacemakers, vascular grafts).
Staphylococcus aureus typical diseases: bacteremia/endocarditis
One of the most common isolates from blood cultures (associated with concurrent foreign-body infections or skin/soft tissue infection) and a common cause of heart valve infection (endocarditis).
Staphylococcus aureus Antibiotic Resistance.
The development of antibiotic resistance is of particular concern in this organism. For example, there has been a progressive acquisition of genes which confer resistance to penicillins, followed by resistance to methicillin, and the more recently emerging resistance to vancomycin . The most important of these is methicillin resistance (“methicillin- resistant Staph aureus” MRSA).
(Gram + Cocci) Staphylococcus epidermidis
This is the prototype of the group of staphylococcal species collectively termed SSNA (“staph species, not aureus”), or CNS (“coagulase negative staphylococcus”).
• These are generally considered to be normal skin flora and relatively non-pathogenic. However in certain circumstances, it is associated with various sorts of localized infection. Infections are typically associated with various sorts of foreign bodies, e.g., catheters, shunts, hip prostheses, artificial (or damaged) heart valves. The members of this group that are most often associated with disease are those that produce “slime”, an extracellular glycocalyx that allows the organisms to adhere very tenaciously to the various implanted devices, and allows them to grow in a protected biofilm on the surface of the device.
• Infections are quite difficult to treat and often require removal of the device. o Antibiotic resistance (including methicillin) and
o Limited accessibility of the drug to the bacteria within the biofilm
The genus Streptococcus (and relatives)
Gram-positive cocci often in chains or pairs
• Catalase negative (Staphylococci are catalase positive)
o Streptococcus pyogenes
o Streptococcus pneumoniae
o “Viridans” streptococci
o Enterococcus faecalis/Enterococcus faecium
Streptococcus pyogenes (“Group A Strep”, GAS)
Pharyngeal infection- Strep throat. Streptococcus pyogenes is the causative agent of common “strep throat”. Untreated, this infection of the pharynx generally self-limiting and resolves in a
couple weeks. Among the Group A strep that cause human disease, there are over 70 serotypes based on antigenic differences in the M-protein. Antibody against the M-protein is protective against disease caused by the same streptococcal serotype, but individuals remain susceptible to infection by isolates with serologically distinct M-protein. Transmission is generally by contact with nasal secretions of an infected individual, or by droplets produced by coughing, etc.
streptococcus pyogenes: Skin and wound infections
Group A Strep are associated with infections of the skin and wounds. The typical lesion is that of a spreading infection of the cutaneous and subcutaneous tissues (cellulitis). Bacteremia and sepsis are possible. GAS produce a variety of hydrolytic enzymes that act in concert to break down tissue and damage or kill phagocytic cells, thereby facilitating spread of the organism through the tissues.
streptococcus pyogenes: Post-streptococcal diseases.
Glomerulonephritis- an immune complex disease that may follow skin or pharyngeal infection by Group A strep. Rheumatic fever- This is an autoimmune inflammatory disease characterized by fever and inflammation of the heart, joints, and other tissues. RF is generally thought to result from the production of self-reactive antibodies produced in response to pharyngeal infection by Group A Strep. In RF, the heart tissue itself is NOT colonized by the infecting Streptococcal organisms, making the disease distinct from infective (bacterial) endocarditis- a true bacterial infection of the heart valves (e.g., Staphylococcus epidermidis).
Streptococcus pneumoniae
G+ cocci in pairs (diplococci; “pneumococcus”). Normal flora in UR tract of up to 40% of healthy people
• Diseases include non-invasive and invasive disease:
o Non-invasive: Pneumonia (one of the most frequent causes of bacterial pneumonia in all age groups, world-wide). Sinusitis, otitis media, bronchitis. o Invasive disease: Meningitis, bacteremia/septicemia, pneumonia with septicemia. Predisposing factors include: young or old, alchollism, respiraroty viral infection
Streptococcus pneumoniae Vaccines
Adults- (pneumovax, PPSV23) Commonly refered to as the “pneumonia vaccine”. Provides measurable (but by no means complete) protection against INVASIVE disease in elderly and immunocompromised adults. Ironically, does NOT provide protection against pneumonia. Children- Hepta-valent (Prevnar) and newer 13-valent (Prevnar 13) vaccines in kids are remarkably successful at reducing disease in vaccinated. Confers a degree of “herd immunity” on unvaccinated individuals. Rather unexpectedly, widespread vaccination of kids also reduced vaccine-type pneumococcal carriage across all age groups. Some studies suggest efficacy is threatened by “serotype replacement”.